With PBS-listed neoadjuvant regimens marking a landmark shift in melanoma treatment and redefining standards of care, clinicians now need practical, real-world guidance to implement these therapies effectively within multidisciplinary practice.

Join Melanoma Institute Australia for a case-based hybrid symposium, hosted by Professor Georgina Long AO, to gain real-world insights into patient selection, treatment timing, toxicity management, and pathological assessment. You’ll also hear about the latest research efforts driving further
improvements in patient outcomes.

Join the live stream to take part in this interactive learning session.